A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease
- PMID: 18282093
- PMCID: PMC2242832
- DOI: 10.1371/journal.ppat.0040029
A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease
Abstract
Chikungunya virus (CHIKV) is a re-emerging arbovirus responsible for a massive outbreak currently afflicting the Indian Ocean region and India. Infection from CHIKV typically induces a mild disease in humans, characterized by fever, myalgia, arthralgia, and rash. Cases of severe CHIKV infection involving the central nervous system (CNS) have recently been described in neonates as well as in adults with underlying conditions. The pathophysiology of CHIKV infection and the basis for disease severity are unknown. To address these critical issues, we have developed an animal model of CHIKV infection. We show here that whereas wild type (WT) adult mice are resistant to CHIKV infection, WT mouse neonates are susceptible and neonatal disease severity is age-dependent. Adult mice with a partially (IFN-alpha/betaR(+/-)) or totally (IFN-alpha/betaR(-/-)) abrogated type-I IFN pathway develop a mild or severe infection, respectively. In mice with a mild infection, after a burst of viral replication in the liver, CHIKV primarily targets muscle, joint, and skin fibroblasts, a cell and tissue tropism similar to that observed in biopsy samples of CHIKV-infected humans. In case of severe infections, CHIKV also disseminates to other tissues including the CNS, where it specifically targets the choroid plexuses and the leptomeninges. Together, these data indicate that CHIKV-associated symptoms match viral tissue and cell tropisms, and demonstrate that the fibroblast is a predominant target cell of CHIKV. These data also identify the neonatal phase and inefficient type-I IFN signaling as risk factors for severe CHIKV-associated disease. The development of a permissive small animal model will expedite the testing of future vaccines and therapeutic candidates.
Conflict of interest statement
Figures
Similar articles
-
ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation.PLoS Pathog. 2011 Oct;7(10):e1002322. doi: 10.1371/journal.ppat.1002322. Epub 2011 Oct 20. PLoS Pathog. 2011. PMID: 22028657 Free PMC article.
-
Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus.J Virol. 2014 Mar;88(5):2414-25. doi: 10.1128/JVI.02716-13. Epub 2013 Dec 11. J Virol. 2014. PMID: 24335291 Free PMC article.
-
Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity.PLoS Negl Trop Dis. 2013 Jul 25;7(7):e2343. doi: 10.1371/journal.pntd.0002343. Print 2013. PLoS Negl Trop Dis. 2013. PMID: 23936572 Free PMC article.
-
Focus on Chikungunya pathophysiology in human and animal models.Microbes Infect. 2009 Dec;11(14-15):1197-205. doi: 10.1016/j.micinf.2009.09.002. Epub 2009 Sep 6. Microbes Infect. 2009. PMID: 19737626 Review.
-
Chikungunya virus pathogenesis: From bedside to bench.Antiviral Res. 2015 Sep;121:120-31. doi: 10.1016/j.antiviral.2015.07.002. Epub 2015 Jul 6. Antiviral Res. 2015. PMID: 26159730 Review.
Cited by
-
Chikungunya-specific IgG and neutralizing antibody responses in natural infection of Chikungunya virus in children from India.Arch Virol. 2021 Jul;166(7):1913-1920. doi: 10.1007/s00705-021-05049-3. Epub 2021 Apr 27. Arch Virol. 2021. PMID: 33907861
-
Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion.Viruses. 2015 Jul 7;7(7):3647-74. doi: 10.3390/v7072792. Viruses. 2015. PMID: 26198242 Free PMC article. Review.
-
Reemergence of Chikungunya virus in Indian Subcontinent.Indian J Virol. 2010 Jun;21(1):8-17. doi: 10.1007/s13337-010-0012-1. Epub 2010 Sep 3. Indian J Virol. 2010. PMID: 23637474 Free PMC article.
-
Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors.J Virol. 2020 Nov 23;94(24):e01500-20. doi: 10.1128/JVI.01500-20. Print 2020 Nov 23. J Virol. 2020. PMID: 32999033 Free PMC article.
-
A nonhuman primate model of chikungunya disease.J Clin Invest. 2010 Mar;120(3):657-60. doi: 10.1172/JCI42392. Epub 2010 Feb 22. J Clin Invest. 2010. PMID: 20179348 Free PMC article.
References
-
- Mason PJ, Haddow AJ. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952–53; an additional note on Chikungunya virus isolations and serum antibodies. Trans R Soc Trop Med Hyg. 1957;51:238–240. - PubMed
-
- Enserink M. Infectious diseases. Massive outbreak draws fresh attention to little-known virus. Science. 2006;311:1085. - PubMed
-
- Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007;7:319–327. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
